NOWDiagnostics, an Arkansas company that specializes in the development and manufacture of next-generation lateral flow assays, is delighted to announce a partnership with Future Healthcare, a European distribution company headquartered in Portsmouth, Engla...

NOWDiagnostics is pleased to announce that Sina Dadgar, PhD, has accepted the position of Director of Instrumentation, effective October 2022. This new position is vital to further the development of NOWDiagnostics’ handheld analyzer technologies. As Direct...

On May 25, 2022, NOWDiagnostics was granted CE Mark for the ADEXUSDx® Syphilis rapid test. This treponemal assay requires only 1 drop of whole blood to perform and yields a laboratory quality result in just 15 minutes. The test has 100% sensitivity for all ...

Beth Cobb, COO, Erin Shahan, Sales Lead, and Kevin Clark, CSO, represented NOWDiagnostics at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo, July 24th-28th in Chicago, IL. The team was pleased to introduce their technology throughout the wee...

To respond to increasing demand for diagnostic tests, NOWDiagnostics has invested in the development of a fully automated production system.  The new automation can yield capacity of 2M ADEXUSDx® diagnostic tests per month and has the potential to reduce th...

Jim Haworth is a proven executive with a 37-year background as Chairman, Board Member, and CEO in the direction, leadership and implementation of business operations, merchandising and marketing solutions, including: strategic planning, financial structurin...